Regulation of the neuronal norepinephrine transporter by endothelin-1 and -3 in the rat anterior and posterior hypothalamus

Neurochemistry International

Volumn 53, Issue 6-8, 2008, Pages 207-213

  Hope, Sandra I ^a   Schmipp, Josefina ^a   Rossi, Andres H ^a   Bianciotti, Liliana G ^b   Vatta, Marcelo S ^a  

^a Universidad de Buenos Aires   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Anterior hypothalamic region; Endothelin 1; Endothelin 3; Neuronal norepinephrine transporter; Neuronal norepinephrine uptake; Posterior hypothalamic region

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN 3; NORADRENALIN TRANSPORTER; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANTERIOR HYPOTHALAMUS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; MALE; NEUROTRANSMISSION; NONHUMAN; NORADRENALIN UPTAKE; POSTERIOR HYPOTHALAMUS; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

ANIMALS; CELL MEMBRANE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENDOCYTOSIS; ENDOTHELIN-1; ENDOTHELIN-3; HYPOTHALAMUS, ANTERIOR; HYPOTHALAMUS, POSTERIOR; KINETICS; MALE; NEURONS; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTIC MEMBRANES; UP-REGULATION;

RATTUS;

EID: 56349143679     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2008.07.003     Document Type: Article

References (33)

1. Apparsundaram S., Galli A., de Felice L.J., Hartzell H.C., and Blakely R.D. Acute regulation of norepinephrine transport. I. Protein kinase C-linked muscarinic receptor influence transport capacity and transporter density in SK-N-SH cells. J. Pharmacol. Exp. Ther. 287 (1998) 733-743
2. Backs J., Bresch E., Lutz M., Kristen A.V., and Haass M. Endothelin-1 inhibits the neuronal norepinephrine transporter in hearts of male rats. Cardiovasc. Res. 67 (2005) 283-290
3. Blakely R.D., de Felice L.J., and Hartzell H.C. Molecular physiology of norepinephrine and serotonin transports. J. Exp. Biol. 196 (1994) 263-281
4. Bönisch H., and Brüss M. The norepinephrine transporter in physiology and disease. Handb. Exp. Pharmacol. 175 (2006) 485-524
5. Bryan-Lluka L.J., Paczkowski F.A., and Bonish H. Effects of short- and long-term exposure to c-AMP and c-GMP on the noradrenaline transporter. Neuropharmacology 40 (2001) 607-617
6. di Nunzio A.S., Jaureguiberry M.S., Rodano V., Bianciotti L.G., and Vatta M.S. Endothelin-1 and -3 diminishe neuronal NE release through a NO mechanism in rat anterior hypothalamus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283 (2002) 615-622
7. di Nunzio A.S., Legaz G., Rodano V., Bianciotti L.G., and Vatta M.S. Modulatory effect of endothelin-1 and -3 on neuronal norepinephrine release in the rat posterior hypothalamus. Regul. Pept. 118 (2004) 51-59
8. Eisenhofer G. The role of neuronal and extraneuronal plasma membrane transporter in the inactivation of peripheral catecholamines. Pharmacol. Ther. 91 (2001) 35-62
9. A receptors mediate atypical endothelin-1 induced contraction in sheep isolated tracheal smooth muscle. J. Pharmacol. Exp. Ther. 289 (1999) 1385-1390
10. Hiller-Sturmhofel S., and Bartke A. The endocrine system: an overview. Alcohol Health Res. World 22 (1998) 153-164
11. B receptor involving multiple signalling pathways in the anterior hypothalamus. Peptides 25 (2004) 1133-1138
12. Kedzierski R.M., and Yanagisawa M. Endothelin system: the double-edged award in health and disease. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 851-876
13. Koizumi S., Kataoka Y., Niwa M., and Kumakura K. Endothelin-3 stimulates the release of catecholamine from cortical and striatal slices of the rat. Neurosci. Lett. 134 (1992) 219-222
14. Kuwaki T., Kurihara H., Cao W.H., Kurihara Y., Unekawa M., Yazaki Y., and Kumada M. Physiological role of brain endothelin in the central autonomic control: from neuron to knockout mouse. Prog. Neurobil. 51 (1997) 545-579
15. Kuwaki T., Ling G.Y., Onodera M., Ishii T., Nakamura A., Ju K.H., Cao W.H., Kumada M., Kurihara H., Yazaki Y., Ohuchi T., Yanagisawa M., and Fukuda Y. Endothelin in the central control of cardiovascular and respiratory functions. Clin. Exp. Pharmacol. Physiol. 26 (1999) 989-994
16. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
17. Mandela P., and Ordway G.A. The norepinephrine transporter and its regulation. J. Neurochem. 97 (2006) 485-524
18. Mayer A.F., Schroeder C., Heusser K., Tank J., Diedrich A., Schmieder R.E., Luft F.C., and Jordan J. Influences of norepinephrine transporter function on the distribution of sympathetic activity in human. Hypertension 48 (2006) 120-126
19. Morgazo C., Perfume G., Legaz G., di Nunzio A., Hope S.I., Bianciotti L.G., and Vatta M.S. Involvement of nitric oxide pathways in short term modulation of tyrosine hydroxylase activity by endothelins 1 and 3 in the rat anterior hypothalamus. Biochem. Biophys. Res. Commun. 334 (2005) 796-802
20. Motte S., McEntee K., and Naeije R. Endothelin receptor antagonists. Pharmacol. Ther. 110 (2006) 386-414
21. B-selective ligands. Mol. Pharmacol. 52 (1997) 582-589
22. Oparil S., Chen Y.F., Berecek H., Calhoun D.A., and Wyss J.M. The role of the central nervous system in hypertension. In: Laragh J.H., and Brenner R.H. (Eds). Hypertension: Pathophysiology, Diagnosis, and Management (1995), Raven Press, New York 713-740
23. Palkovits M., and Brownstein M.J. Maps and Guide to Microdissection of the Rat Brain (1988), Elsevier, New York
24. Perfume G., Morgazo C., Nabhen S., Batistone A., Hope S.I., Bianciotti L.G., and Vatta M.S. Short-term regulation of tyrosine hydroxylase activity and expression by endothelin-1 and endothelin-3 in the rat posterior hypothalamus. Regul. Pept. 142 (2007) 69-77
25. Perfume G., Nabhen S.L., Riquelme Barrera K., Otero M.G., Bianciotti L.G., and Vatta M.S. Long-term modulation of tyrosine hydroxylase activity and expression by endothelin-1 and -3 in the rat anterior and posterior hypothalamus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294 (2008) R905-R914
26. Schlaich M.P., Lambert E., Kaye D.M., Krozowski Z., Campbell D.J., Lambert G., Hastings J., Aggarwal A., and Esler M.D. Sympathetic augmentation in hypertension. Role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension 43 (2004) 169-175
27. B receptors in cardiovascular disease. Annu. Rev. Pharmacol. Toxicol. 47 (2007) 731-759
28. Schroeler S., Apparsundaram S., Wiley R.G., Miner L.H., Sesack S.R., and Blakely R.D. Immunolocalization of the cocain- and antideppresant-sensitive l-norepinephrine transporter. J. Comp. Neurobiol. 420 (2000) 211-232
29. 3H] nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding. J. Pharmacol. Exp. Ther. 260 (1992) 427-436
30. Torres G.E., and Amara S.G. Glutatmate and monoamine transporters: new visions of form and function. Curr. Opin. Neurobiol. 17 (2007) 304-312
31. van den Buuse M., and Webber K.M. Endothelin and dopamine release. Prog. Neurobiol. 60 (2000) 385-405
32. Vatta M.S., Presas M., Bianciotti L.G., Zarrabeita V., and Fernández B.E. B and C types natriuretic peptides modulate norepinephrine uptake and release in the rat hypothalamus. Regul. Pept. 65 (1996) 175-184
33. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., and Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332 (1988) 411-415